# Global Lomitapide Pregnancy Exposure Registry

> **NCT02399839** · — · TERMINATED · sponsor: **Amryt Pharma** · enrollment: 5 (actual)

## Conditions studied

- Pregnancy

## Interventions

- **DRUG:** lomitapide

## Key facts

- **NCT ID:** NCT02399839
- **Lead sponsor:** Amryt Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** The PER objective has been integrated into the LOWER protocol.
- **Last updated:** 2022-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02399839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02399839, "Global Lomitapide Pregnancy Exposure Registry". Retrieved via MORVS 2026-09-29 from https://api.ai-analytics.org/clinical/NCT02399839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*